{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "The U.S. Supreme Court could have the ultimate say on whether Arizona's new abortion-medication restrictions &#8212; considered the most stringent in the nation, but put on hold by a federal appeals court &#8212; should take effect.", "headline": {"main": "Arizona Attorneys Appeal Abortion-Rule Injunction", "print_headline": "Arizona Attorneys Appeal Abortion-Rule Injunction"}, "abstract": null, "print_page": null, "word_count": "502", "_id": "53e13e50798810409a1b67a0", "snippet": "The U.S. Supreme Court could have the ultimate say on whether Arizona's new abortion-medication restrictions &#8212; considered the most stringent in the nation, but put on hold by a federal appeals court &#8212; should take effect.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/08/05/us/ap-us-arizona-abortion-restrictions.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-08-05T16:26:56Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Upshot", "lead_paragraph": "Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs\u2019 pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.", "headline": {"main": "The Obscure Drug With a Growing Medicare Tab", "kicker": "The Upshot", "print_headline": "An Obscure Drug Rings Up a Growing Medicare Tab", "content_kicker": "Losing Cost Control "}, "abstract": "The Upshot; experts question effectiveness of HP Acthar Gel, drug made from pigs\u2019 pituitary glands, which cost Medicare more than $141 million in 2012, up from $7 million in 2008; explosive growth illustrates how Medicare's prescription drug program is struggling to contain taxpayer burden of expensive therapies aimed at rare conditions.", "print_page": "3", "word_count": "2100", "_id": "53df9ff8798810168b3f698b", "snippet": "Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs\u2019 pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/05/upshot/the-obscure-drug-with-a-growing-medicare-tab.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-thumbWide.png", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-thumbWide.png", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-articleLarge.png", "height": 450, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-articleLarge.png", "xlargeheight": "450"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/05/upshot/05up-medicare/05up-medicare-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/05/upshot/05up-medicare/05up-medicare-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Questcor Pharmaceuticals Incorporated", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Seizures (Medical)", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Mallinckrodt Pharmaceuticals", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Acthar (Drug)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Charles", "lastname": "ORNSTEIN"}], "original": "By CHARLES ORNSTEIN"}, "document_type": "article", "pub_date": "2014-08-05T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Another sampling of the outpouring of responses to The Times\u2019s editorial series.", "headline": {"main": "Legalizing Marijuana: Pros and Cons", "kicker": "Letters", "print_headline": "Legalizing Marijuana: Pros and Cons", "content_kicker": "Letters"}, "abstract": null, "print_page": "22", "word_count": "852", "_id": "53dad29479881078147dde55", "snippet": "Another sampling of the outpouring of responses to The Times\u2019s editorial series.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/01/opinion/Legalizing-Marijuana-Pros-and-Cons.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-articleLarge.jpg", "height": 762, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-articleLarge.jpg", "xlargeheight": "762"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/01/opinion/0801LettersMARIJUANA/0801LettersMARIJUANA-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Discrimination", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Drug Enforcement Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Teenagers and Adolescence", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Marijuana", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "United States", "is_major": "N", "rank": "4", "name": "glocations"}], "byline": [], "document_type": "article", "pub_date": "2014-08-01T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 3, "offset": 0, "time": 22}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}